New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
Philadelphia-negative myeloproliferative neoplasms (MPN) are aggressive diseases characterized by clonal proliferation of myeloid stem cells. The clonal process leads to excessive red cells production, platelets production, and bone marrow fibrosis. According to the phenotype, MPN can be classified...
Saved in:
Main Author: | Domenico Penna |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/61c8db4b2543475f9aad70a2daa5087c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
by: Vaddi K, et al.
Published: (2016) -
Disseminated tuberculosis with myelofibrosis presentation: a case report
by: Mahdi Khatuni, et al.
Published: (2021) -
Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
by: Magdalena M. Brune, et al.
Published: (2021) -
Polycythemia Vera (PV): Update on Emerging Treatment Options
by: Benevolo G, et al.
Published: (2021) -
The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases
by: Marco Pizzi, et al.
Published: (2021)